Table 3 Cox regression analyses for predictors of systemic embolism events

From: Clinical characteristics and prognostic importance of anticoagulant use in ischemic left ventricular aneurysm: a retrospective cohort study

 

Univariate analysis

Multivariable analysis*

 

SHR (95% CI)

P-value

SHR (95% CI)

P-value

Age

1.02 (1.00−1.04)

0.044

  

Male

0.96 (0.58−1.58)

0.869

  

BMI

0.99 (0.92−1.05)

0.673

  

Prior atrial fibrillation

2.20 (1.33−3.65)

0.002

1.96 (1.17−3.26)

0.010

Hypertension

2.60 (1.56−4.32)

<0.001

  

Diabetes mellitus

1.84 (1.17−2.89)

0.008

  

Prior stroke/TIA

5.27 (3.28−8.47)

<0.001

5.76 (3.39−9.79)

<0.001

Smoking

1.19 (0.75−1.89)

0.465

  

Drinking

1.02 (0.53−1.97)

0.960

  

Anticoagulant agent

0.34 (0.17−0.66)

0.001

0.21 (0.10−0.44)

<0.001

LVT

2.92 (1.56−5.46)

0.001

3.82 (2.20−6.62)

<0.001

Akinesis in apical segments

2.20 (1.39−3.50)

0.001

1.83 (1.14−2.93)

0.011

Years of inclusion

1.08 (1.00−1.16)

0.060

  
  1. All statistical tests were two-sided at a significance level of 0.05.
  2. CI confidence interval, SHR subdistribution hazard ratio, BMI body mass index, TIA transient ischemic attack, LVT left ventricular thrombus.
  3. *Nonsignificant variables were eliminated after the multivariable model run, including age, male, BMI, hypertension, diabetes mellitus, smoking, drinking and years of inclusion.
Back to article page